Clinical Trial Update: NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for NX in luminal B breast cancer patients after neoadjuvant chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• NX

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN